$BBh(B26$B2sF|K\IBM}3X2q6a5&;YIt3X=Q=82q8!F$>INc(B

597$B!'(B$B==Fs;XD2 $BJuDM;TN)IB1!!!(B $BN.EDCR;K(B
$BEjI<7k2L(B 24$B!!(B 10 5 3 3 1 2 1$B!!(B 1$B!!(B 1$B!!(B 1$B!!(B	$B!!!!!!!!!!!!(B Carcinoma ($B$&$A(BAnaplastic carcinoma$B!K(B ($B$&$A(BUndifferentiated carcinoma$B!K(B ($B$&$A(BSarcomatoid carcinoma$B!K(B ($B$&$A(BPleomorphic carcinoma$B!K(B ($B$&$A(BAdenocarcinoma$B!K(B ($B$&$A(BPoorly differentiated adenocarcinoma with rhabdoid feature$B!K(B Rhabdomyosarcoma Malignant rhabdoid tumor Gastrointestinal stromal tumor (GIST) Malignant fibrous histiocytoma (MFH)
$B8!F$7k2L(B	Adenocarcinoma
$B>INc(B	80$B:PBe!"=w@-(B
$B7P2a(B	$B!Z $B!Z8=IBNr![#1G/#3%v7nA0$h$j#3#8!]#3#9EY$NH/G.!"A4?H7qBU$r$_$H$a$?!#K\1!@:::$K$FIO7l!"#C#T!"#M#R#I$K$F==Fs;XD2!"g9F,It$K $B!ZFy4c=j8+![ $B!Z82Hy6@=j8+![ $B!ZLdBjE@![AH?%?GCG$K$D$$$F!#(B
$B

598$B!'g/fyA0LLJ"Kl2<$KH/@8$7$?FpIt $BEDIm6=Iw2qKLLnIB1!NW>2IBM}It(B(1) $B!"5~BgIB1!IBM}It(B(2)$B!"Bg:e;u2JBg3X8}9PIBM}3X9V:B(B(3) $BBkAc98>;(B1)$B!"2OLnJ8I'(B1)$B!"9a7nF`JfH~(B1)$B!"1|LnCN;R(B2)$B!"5HBtL@I'(B2)$B!"OBEb2mGn(B3)
$BEjI<7k2L(B 6 6 1 1 1 2 1 3 1 1 1 1 1	$B!!(B Solitary fibrous tumor Inflammatory myofibroblastic tumor Stromal sarcoma Benign fibrous tumor EGIST Leiomyosarcoma Smooth muscle tumor; borderline Leiomyoma Perineurinoma Paraganglioma Aggressive angiomyxoma Cellular angiofibroma GANT
$B8!F$7k2L(B	Solitary fibrous tumor
$B>INc(B	60$B:PBeA0H>!!CK@-(B
$B7P2a(B	$B!Z $B!Z4{1}Nr![(B10$B:PBe!'Cn?b1j!&J"Kl1j!J $B!Z2HB2Nr![FC5-$9$Y$-$3$H$J$7(B $B!Z8=IBNr![#1G/$[$IA0$+$i!"1&2I>u$,$J$$$?$aJ|CV$7$F$$$?!#=y!9$K.;yF,Bg0L$K$J$j!"G"0U$b@ZGw$7!"BgJX:Y$/$J$C$?$?$a6a0eR2p$5$l!" $B!ZF~1!;~8!::@.@S(B($BC10LN,(B)$B![(BHb 14.5 Ht 42% WBC 3100 Plt 16.2$BK|!!(B CRP <0.10 GOT 50 GPT 33 CEA 1.5 CA19-9 <2.0 $B!Z2E*$K$O9MN8$5$l$?!J(BFig1$B!KD>D2$O $B!ZAH?%A|![7l4I<~0O@-$rI@-:YK&?;=a$rH<$$$J$,$i!"Hf3SE*6Q0l$JKB?n7A:YK&$,B+>u$KA}@8$7!"=< $B!ZLdBjE@![(B $B#1!%AH?%?GCG$J$i$S$K(B $BAwIUI8K\!'
$B	1$B!"(B2$B!"(B3$B!"(B4

599$B!'$SL!@-GYK&=P7l$NIBA|$rDh$7$?GY86H/e0LS4b$N#1K68!Nc(B $BBg:e@V==;zIB1!!!IBM}It(B(1)$B!"8F5[4o2J(B(2)$B!"!!(B $B?7Bp2m9,(B1)$B!"(BHwang MH2)$B!"LVC+NI0l(B2)
$BEjI<7k2L(B 25 1 1	$B!!(B Choriocarcinoma Metastatic undifferentiated carcinoma (Diffuse alveolar hemorrhage)
$B8!F$7k2L(B	Choriocarcinoma
$B>INc(B	40$B:PBeA0H>!"=w@-!"4G8n;U!#(B
$B7P2a(B	$B$SL!@-GYK&=P7l(B (diffuse alveolar hemorrhage, DAH) $B$ON>GY$K9-HO$J$SL!@-=P7l$rMh$?$7!"5^B.$K;`$NE>5"$r$?$I$k5)$JIBBV$G!"$=$N860x$H$7$F$O(B Goodpasture $B>I8u72$d(B ANCA $B4XO"7l4I1j$,BgH>$r@j$a!"GYK&LS:Y7l4I1j(B (alveolar capillaritis) $B$,B?$/$N>INc$G>ZL@$5$l$k!#NW>2E*$KDj7?E*$J(B DAH $B$NIBA|$rDh$7!"K68!$K$FGY86H/$Ne0LS4b$H$=$N9-HO$JGYFbE>0\$,(B DAH $B$N860x$H9M$($i$l$?6K$a$F5)$J#1Nc$rDs<($9$k!#(B $B!ZNW>27P2a![;`K4Ls#1#3F|A0$+$i4%@-31SV!"HyG.!"O+:n;~8F5[:$Fq$"$j!#5^7c$K>I>u$,?J9T$7$?$?$aF~1!!##X@~>e$G$OA4GYLn$K$o$?$k$SL!@- $B7k@a1F$rG'$a$?!#5$4I;Y6@$G$O:Y5$4I;YFb$K7l1U$,= $BM^@):^EjM?!"7l^y8r49!"?M9)8F5[4o4IM}$J$I$N<#NE$KDq93@-$G!"F~1!8e#8F|L\$K;`K4!#(B $B7P2aCf?UITA4$O$J$/!"g186IB$r<(:6$9$k=j8+$b$J$+$C$?!#934pDlKl93BN!"(BANCA $B$O1"(B $B@-!#;`8e$NJ]B87l@6$N8!::$G(B beta-HCG 506 ng/mL $B$H0[>o9bCM$r<($7$?!#(B $BK68!;~!"GY$O(B 1,135g$B!"(B1,055 g$B!#N>GYA0MU$K$o$?$k9bEY$N(B DAH $B$rG'$a$?!#1&2<(B $BMU$K7B(B 3.7 cm $B$NGY86H/e0LS4b!J=c?h7?!K$rG'$a!"4N!"I{?U!"g9!"9C>uA#!"MqAc$KE>(B $B0\$rG'$a$?!JMqAc$NB&@-!"82Hy6@E*%5%$%:$G!"MqAc86H/$H$O9M$($i$l$J$$!K!#(B $B;R5\!"Mq4I$KCxJQL5$7!#GYFb$K0\$rG'$a!"(B DAH $B$N860x$H9M$($i$l$?!#(B $B!JAwIUI8K\$OGY!K(B
$B	1$B!"(B2$B!"(B3$B!"(B4$B!"(B5$B!"(B6

600$B!'%0%k%F%sITBQ>I$K(BB cell lymphoma$B$HN`Gr7lIBH?1~$r9gJ;$7$?#1Nc(B $B?@8M;TN)Cf1{;TL1IB1!!!NW>2IBM}2J(B(1)$B!">C2=4oFb2J(B(2) $B:#0f9,90(B1)$B!"Gr:,GnJ8(B1)$B!"@DLZ?.M5(B2)$B!"2,EDL@I'(B2)
$BEjI<7k2L(B 27$B!!!!(B 13$B!!(B 6 11$B!!!!(B 1$B!!!!(B 1$B!!!!(B 3$B!!!!(B 1$B!!!!(B 1$B!!!!(B	$B!!(B Malignant lymphoma $B!J$&$A!!(BB-cell type$B!K(B $B!J$&$A!!(BDiffuse large B-cell type$B!K(B =================================== Leukemoid reaction Chronic myeloproliferative disease MDS Myeloid hyperplasia + hemophagocytosis Plasmacytosis Lymphoma associated hemophagocytic syndrome
$B8!F$7k2L(B	Malignant lymphoma
$B>INc(B	70$B:PBeA0H>!"=w@-(B
$B7P2a(B	$B!Z $B!Z4{1}Nr!"2HB2Nr![FC5-$9$Y$-=j8+$J$7!#(B $B!Z8=IBNr![0JA0$+$i%Q%s?)@]A0$+$iBN=E8:>/$,82Cx$H$J$j!"%^%/%m%"%_%i!<%<7l>I$H$7$F7P2a4Q;!$5$l$k$bBN=E8:>/$,$D$E$-!"#3G/H>A0$K$O==Fs;XD2DY$r;XE&$5$lFbI~<#NE$rI>u$N5^7c$JA}0-$HIO7l$N?J9T$rG'$a!"@:::2CNEL\E*$GEv1!>R2pF~1!$H$J$C$?!#(B $B!Z7P2a![F~1!;~?HD9(B 152.5cm$B!"BN=E(B41kg(3$BG/A0(B64kg)$B$G!"Fb;k6@8!::$G==Fs;XD2(B/$B2sD2KvC\:Y$JIBNrD0.G~@=IJ@]o9bCM!J(BIgG;177U/ml($B!c(B25)$B!!(BIgA;303U/ml($B!c(B25)$B!K$r<($7$?!#%0%k%F%s=|5n?)(B(Gluten Free Diet;GFD)$B$G2I>u$O2~A1$7!"%0%k%F%s7P8}Ii2Y%F%9%H$K$FSREG!&2o=8@Q$J$7!#(B $B30Mh$K$F(BGFD$B$r7QB3$7!"2C<:$H(B10kg$B$NBN=EA}2C$rG'$a$?!#$7$+$7$=$N8e(BGFD$B$NITE0Dl$+$i2/$7$O$8$a!";`K4#1G/A0$+$i(BGFD$B$rE0Dl$7$?$,>I>u$O2~A1$;$:!"(BPSL$B!J(B35mg/day$B!KFbI~3+;O$7$?$H$3$m2.9/>uBV$rJ]$C$F$$$?!#7P2aCf!"Gr7l5e#1(B-$B#2K|(B/mm3 $B$,;}B3$7$F$$$?$,!"J,2h$ON`Gr7lIBH?1~%Q%?!]%s$G$"$C$?!#(B $B!!H>G/A0$K>C2=4I@|9&$K$h$kFMA3$N2.D2@Z=|=Q$r9T$C$?!JI8K\(B2$B!K!#LH1V@w?'$G$OL)$K?;=a$9$k$d$dBg7?$N%j%s%Q5e$,(BL26$BM[@-!"(BUCHL1$B1"@-$G$"$C$?!#(B $B0l%v7nA0$K7PfjLgE*>.D2%U%!%$%P!<;\9T!#2sD2$K;6:_@-$KpyN3>uN45/$H$S$i$s$rG'$a!"(BLymphoma$B:FH/$r5?$&=j8+$O$J$+$C$?$,!"A0=hCV$N2<:^$rAV7rH~Cc(B($B$O$HG~!&BgG~$J$I%0%k%F%s4^M-(B)2L$B$GFbI~$7$?$?$aMbF|$h$j2uBV$H$J$C$?!#0U<1>c32!"(BIVH$B!"%+%F!<%F%k46@w!"8mSk@-GY1j$J$I$rJ;H/$7!"(BARDS$B?J9TCx$7$/8F5[ITA4$G;`K4!#$^$?!"Kv4|$K$OKv>?7lGr7l5e$O#1#2K|(B/mm3$B$HCxA}$7$F$$$?!#!JI8K\(B3$BK68!DGBN9|?q!K(B $B!ZLdBjE@![(B $B#1!%(B Celiac $BIB$K9gJ;$9$k%j%s%Qo(BT$B:YK&@-$G$"$k$N$K(BB$B:YK&@-$G$"$C$?E@!#(B $B#2!%(B $B9|?qIBJQ$rN`Gr7lIBH?1~$H$7$FNI$$$+!#(B
$B

601$B!'9C>uA# $B?@8MBg3XImB0IB1!IBM}It(B $BLnED>0;R!";Be!"BgNS@iJf!"2#:j9((B
$BEjI<7k2L(B 16$B!!(B 6 4 3 1 1 1 2$B!!(B 3$B!!(B 1$B!!(B 1$B!!(B 2$B!!(B 1$B!!(B 1$B!!(B	$B!!(B Thyroid cancer $B!J$&$A(BPapillary carcinoma$B!K(B $B!J$&$A(BFollicular carcinoma$B!K(B $B!J$&$A(BMedullary carcinoma$B!K(B $B!J$&$A(BMixed medullary-follicular carcinoma$B!K(B $B!J$&$A(BSclerosing mucoepidermoid carcinoma$B!K(B $B!J$&$A(BAnaplastic carcinoma with $B!!(Bangiosarcomatous feature$B!K(B Follicular adenoma Angiosarcoma Hemangioma Sclerosing hemangioma Adenomatous goiter Amyloidosis Degenerated adenomatous nodule
$B8!F$7k2L(B	Angiosarcoma
$B>INc(B	60$B:MBe8eH>!"CK@-(B
$B7P2a(B	$B!Z4{1}Nr![(B20$B:MBeA0H>!!Cn?b1j!"(B60$B:MBeA0H>!!E|G"IB!"0_DYag@|9&!"<+8JLH1V@-4N1j(B $B!Z2HB2Nr![FC5-$9$Y$-$3$H$J$7(B $B!Z8=IBNr![(B12$BG/A0!"9C>uA#C2=4oFb2J$KF~1!Cf!":FEY9C>uA#uA#2?GCG$N2 $B!Z8!::=j8+![(BCT$B=j8+!'9C>uA#1&MU20\$r5?$&=j8+$OG'$a$J$$!#>0!"0lG/A0$N(BCT$B$HHf3S$7A}Bg798~$OG'$a$J$$!#(B $B7l1U8!::!'(BWBC 98 x 102/mm3$B",(B, Hb 13.5 g/dl$B"-(B, plt 35.2 x 104/mm3$B",(B, HbA1c 9.3%$B",(B, AST 17 IU/l, ALT 8 IU/l, T-bil 0.3 mg/dl, AFP 8 ng/ml, PIVKA$B*"(B 18 mAU/ml, CEA 3.0 ng/ml, $BM7N%(BT3 3.4 pg/ml, $BM7N%(BT4 1.3 ng/dl, TSH 0.296 $B&L(BU/ml$B"-(B, $B%5%$%m%0%m%V%j%s(B 16 ng/ml$B!"(BFNA$B!'7l1U@.J,$N$_$G!"
$B	$B%^%/%m(B1.jpg$B!"(B$B%_%/%m(B1.jpg$B!"(B$B%_%/%m(B2.jpg$B!"(B$B%_%/%m(B3.jpg$B!"(B$B%_%/%m(B4.jpg

602$B!'(B$B2F5($KA}0-$9$kFq<#@-<>?>$r4V;$It$KG'$a$?(B1$BNc(B $B4X@>O+:RIB1!IBM}2J!J#1!K!"HiIf2J!J#2!K(B $BOBED!!D>
$BEjI<7k2L(B 6 3 1 1 1	$B!!(B Hailey-Hailey disease Darier disease Pemphigus vegetans Pemphigus vulgaris Familiar pemphigus
$B8!F$7k2L(B	Hailey-Hailey disease
$B>INc(B	30$B:MBeA0H>!"=w@-(B
$B7P2a(B	$B!Z4{1}Nr![1&F}4b(B($BLs(B5$BG/A0(B) $B!Z8=IBNr(I%$B8=>I![Ls(B10$BG/A0:"$+$iKhG/2F$K8e7[It!$f~c]!$I(c]$J$I$K>.?eaW!$>.G?aW!$$S$i$s!$aPHi$r:.$8$k9HHC$,7+$jJV$7=P8=!%A_aZ$rH<$&!%E_5($K$J$k$H7Z2w$9$k!%$J$*!$Jl?F$*$h$SJlJ}$N2H7O$KF1>I$,$_$i$l$k!%(B $B!ZIBM}AH?%3XE*=j8+![I=Hi2u$KAj@\$9$k3Q2=:YK&$,$"$?$+$b>e$+$iJx$lMn$A$k$h$&$K$_$($k(Bdilapidated brick wall appearance$B$rG'$a$k!%[yM;2r$K$h$kNv7dD>2<$NF}F,AX$O(B1$BAX$N4pDl:YK&$K$*$*$o$l$F>eJ}Nv7dFb$KIT5,B'e0LS>u$KFM=P$9$k!%Nv7dFb$KL@$i$+$J9%;@5e?;=a$O$_$i$l$J$$!%G?aW!$aPHi7A@.$rH<$&ITA43Q
$B	$B8e7[It(B$B!"(B$B8e7[It3HBg(B$B!"(B$BI(c](B$B!"(B$BI(c]3HBg(B$B!"(B$Bf~c](B$B!"(B$Bf~c]3HBg(B $BBPJ*(Bx10$B!"(B$BBPJ*(Bx20

603$B!'1"G9Fb $B5~ETBg3X0e3XItImB0IB1!IBM}It(B(1)$B!"F|K\@V==;z $B5H_7L@I'(B1)$B!";{Eg9d(B1)$B!"1)2lGnE5(B1)$B!"4d:4MU;R(B2)$B!"CfEh0BIK(B1)$B!"??Fi=SL@(B1)
$BEjI<7k2L(B 10$B!!(B 4 4 1 1$B!!(B 2$B!!(B 1$B!!(B 1$B!!(B 3$B!!(B 1$B!!(B 3$B!!(B 1$B!!(B 1$B!!(B 1$B!!(B	$B!!(B Liposarcoma $B!J$&$A(BWell-differentiated$B!K(B $B!J$&$A(BInflammatory$B!K(B $B!J$&$A(BMyxoid$B!K(B Myxoinflammatory fibroblastic sarcoma Mesenchymoma,liposarcoma + botryoid sarcoma Inflammatory myofibroblastic tumor Inflammatory myxohyaline tumor Inflammatory pseudo tumor Lipoma Granulomatous orchitis Nodular periorchitis Peritesticular fibrosis Sclerosing lipogranuloma with atypical multinucleated cells
$B8!F$7k2L(B	Liposarcoma
$B>INc(B	60$B:MBe!"CK@-(B
$B7P2a(B	$B!Z $B!Z4{1}Nr![9b;i7l>I!JLtJ*NEK!Cf!K(B $B!Z8=IBNr![#2#0G/$[$IA0$K%P%9%1%C%H$r$7$F$$$F1"It2%BG!"0J8e1&1"G9Fb$K $B8=>I!'1&1"G9Fb!"@:Ac30$K@:Ac$HF1Bg$N $B8!::=j8+!'7l;;!"@82=3X$KFC5-$9$Y$-;v9`$J$7!" $B!Z2hA|=j8+![(BCT, $B%(%3!<(B,MRI$B$K$F;iKC$N?.9f$r;}$DIT6Qu $B!ZIBM}Fy4c=j8+![1&1"G9Fb(IQ$BK5@:Ac$K:GBg7B(B4.5 cm$B$N#2$D$N7k@a$NL~9g$9$k $B!ZLdBjE@![IBM}AH?%3XE*?GCG(B
$B	$B8GDj8e@5LL(B$B!"(BB$B!"(B$B%k!<%ZA|(B$B!"(BA

604$B!'7[It%j%s%Q@a $BBg:eBg3XIBM}IBBV3X(B(1)$B!"4X@>O+:RIB1!IBM}2J(B(2)$B!"F1Fb2J(B(3) $B@1ED5AI'(B1)$B!"OBEDD>
$BEjI<7k2L(B 14$B!!(B 7 1 1 2 2 4$B!!(B 5$B!!(B 4 1 1$B!!(B 2$B!!(B	$B!!(B Malignant lymphoma $B!J$&$A(BHodgkin lymphoma$B!K(B $B!J$&$A(BLennert$B!G(Bs lymphoma $B!K(B $B!J$&$A(BDiffuse large$B!K(B $B!J$&$A(BT-cell type$B!K(B $B!J$&$A(BMalt type$B!K(B MTX-associated lymphoproliferative disorders Lymphadenopathy $B!J$&$A(BDrug-induced$B!K(B $B!J$&$A(BRA$B4XO"!K(B Eosinophilic lymphadenitis Reactive hyperplasia
$B8!F$7k2L(B	Hodgkin lymphoma
$B>INc(B	50$B:PBe8eH>!"=w@-(B
$B7P2a(B	$B!ZNW>27P2a![(B40$B:P:"$h$j!"K}@-4X@a%j%&%^%A!J(BRA$B!K$K$F<#NE$r$&$1$F$$$?!#<#NELt$H$7$F%j%^%A%k!"%a%H%H%l%-%;!<%H!"%M%*!<%i%k!"%l%_%1!<%I$r;HMQ$7$F$$$?$,!"(BCRP3-$B#50J>e$H(BRA$B$N%3%s%H%m!<%k$OITNI$G$"$C$?!#(B1$B%u7nA0$h$jAM7BIt$KR2pF~1!$H$J$k!#F~1!8e@:::$K$F:87[It!"K5BgF0L.$+$iAM7B%j%s%Q@a$K$+$1$F%j%s%Q@a$N
$B	$B$B!"(B$B6/3HA|(B